Elizabeth Mary Crowley, M.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunoconjugates | 4 | 2019 | 901 | 0.330 |
Why?
|
Mast Cells | 2 | 2022 | 1544 | 0.250 |
Why?
|
Antibodies, Monoclonal | 5 | 2022 | 9274 | 0.230 |
Why?
|
Urticaria | 1 | 2022 | 150 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2022 | 776 | 0.190 |
Why?
|
Lung Injury | 2 | 2023 | 436 | 0.180 |
Why?
|
Radiation Injuries | 3 | 2023 | 1180 | 0.160 |
Why?
|
Osteosarcoma | 1 | 2019 | 881 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 1107 | 0.100 |
Why?
|
Anus Neoplasms | 1 | 2014 | 332 | 0.090 |
Why?
|
Copper Sulfate | 1 | 2010 | 14 | 0.090 |
Why?
|
Hydroquinones | 1 | 2010 | 36 | 0.090 |
Why?
|
Methacrylates | 1 | 2010 | 107 | 0.090 |
Why?
|
Vagina | 1 | 2014 | 825 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 494 | 0.090 |
Why?
|
Gelatin | 1 | 2010 | 225 | 0.080 |
Why?
|
Biomimetic Materials | 1 | 2010 | 179 | 0.080 |
Why?
|
Intestine, Small | 2 | 2012 | 1240 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9240 | 0.080 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2014 | 806 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2530 | 0.070 |
Why?
|
Membrane Glycoproteins | 2 | 2015 | 3771 | 0.070 |
Why?
|
Alopecia | 3 | 2015 | 382 | 0.070 |
Why?
|
Ascorbic Acid | 1 | 2010 | 651 | 0.070 |
Why?
|
Radiometry | 1 | 2010 | 800 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 1170 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 178 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2012 | 1205 | 0.050 |
Why?
|
Polymers | 1 | 2010 | 1621 | 0.050 |
Why?
|
Photons | 1 | 2006 | 588 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
Tryptases | 1 | 2022 | 190 | 0.050 |
Why?
|
Stem Cell Factor | 1 | 2022 | 219 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2015 | 20824 | 0.050 |
Why?
|
Collagen Type I | 1 | 2023 | 592 | 0.050 |
Why?
|
Carcinoma | 1 | 2012 | 2375 | 0.050 |
Why?
|
Neutropenia | 2 | 2014 | 895 | 0.040 |
Why?
|
Fatigue | 2 | 2014 | 1531 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 1585 | 0.040 |
Why?
|
Molecular Imaging | 1 | 2023 | 828 | 0.040 |
Why?
|
Melanoma | 1 | 2014 | 5511 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 4839 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2688 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13693 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2015 | 6896 | 0.030 |
Why?
|
Polyneuropathies | 1 | 2015 | 137 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3270 | 0.030 |
Why?
|
Intestine, Large | 1 | 2012 | 71 | 0.030 |
Why?
|
Drug Eruptions | 1 | 2015 | 297 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.030 |
Why?
|
Pruritus | 1 | 2015 | 361 | 0.030 |
Why?
|
Nausea | 1 | 2014 | 674 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11525 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 497 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11366 | 0.020 |
Why?
|
Defecation | 1 | 2012 | 188 | 0.020 |
Why?
|
Aged | 8 | 2015 | 163288 | 0.020 |
Why?
|
Radiation Dosage | 2 | 2010 | 1928 | 0.020 |
Why?
|
Exanthema | 1 | 2014 | 501 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6364 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2007 | 5263 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 63107 | 0.020 |
Why?
|
Carboplatin | 1 | 2012 | 801 | 0.020 |
Why?
|
Lung | 2 | 2023 | 9857 | 0.020 |
Why?
|
Humans | 13 | 2023 | 744366 | 0.020 |
Why?
|
Middle Aged | 8 | 2015 | 213390 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 624 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 826 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9145 | 0.020 |
Why?
|
Fluorouracil | 1 | 2012 | 1619 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12802 | 0.020 |
Why?
|
Adult | 6 | 2019 | 214052 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29060 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
Female | 9 | 2019 | 380193 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4222 | 0.020 |
Why?
|
Radiography | 2 | 2007 | 7023 | 0.020 |
Why?
|
Anemia | 1 | 2014 | 1503 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1348 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1708 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2014 | 57776 | 0.020 |
Why?
|
Protons | 1 | 2010 | 1127 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6539 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.010 |
Why?
|
Radiotherapy, Conformal | 1 | 2006 | 548 | 0.010 |
Why?
|
Stomach | 1 | 2007 | 697 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1940 | 0.010 |
Why?
|
Carcinoma, Lobular | 1 | 2006 | 484 | 0.010 |
Why?
|
Tumor Burden | 1 | 2007 | 1915 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2006 | 956 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56429 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2879 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13409 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8662 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8432 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2006 | 1100 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2007 | 1624 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5077 | 0.010 |
Why?
|
Pain | 1 | 2012 | 4988 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81201 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2007 | 2727 | 0.010 |
Why?
|
Male | 4 | 2019 | 350115 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14723 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 40559 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168768 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 19905 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7184 | 0.010 |
Why?
|
Liver | 1 | 2007 | 7475 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85779 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2006 | 21748 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 20130 | 0.000 |
Why?
|